Centrally acting histamine H1 antagonists promote the development of amygdala kindling in rats

Neuroscience Letters

Volumn 217, Issue 2-3, 1996, Pages 194-196

  Yokoyama, Hiroyuki ^a   Sato, Mitsumoto ^a   Iinuma, Kazuie ^a   Onodera, Kenji ^b   Watanabe, Takehiko ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Amygdala kindling; Histamine H1 antagonist; Ketotifen; Pyrilamine

Indexed keywords

ANTIHISTAMINIC AGENT; EPINASTINE; HISTAMINE H1 RECEPTOR; KETOTIFEN; MEPYRAMINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EPILEPSY; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0030592509     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)13078-0     Document Type: Article

References (17)

1. [1] Arnold, P.S., Racine, R.J. and Wize, R.A., Effects of atropine, recerpine, 6-hydroxydopamine, and handling on seizure development in rat, Exp. Neurol., 40 (1973) 457-470.
2. [2] Corcoran, M.E., Characteristics of accelerated kindling after depletion of noradrenaline in adult rats, Neuropharmacology, 27 (1988) 1081-1084.
3. [3] Corcoran, M.E., Fibiger, H.C., McCaughran, J.A. Jr. and Wada, J.A., Potentiation of amygdaloid kindling and metrazol-induced seizures by 6-hydroxydopamine in rats, Exp. Neurol., 45 (1974) 118-133.
4. [4] Montesino, H., Villar, M. and Vega, E., and. Rudolph, M.I., Histamine, a neuromodulator of noradrenergic transmission in uterine horns from mice in diestrus, Biochem. Pharmacol., 50 (1995) 407-411.
5. 1 receptor blocking, Physiol. Behav., 51 (1992) 1123-1127.
6. [6] Przegalinski, E., Monoamines and the pathophysiology of seizure disorders. In H.H. Fray and D. Janz (Eds.), Antiepileptic Drugs, Handbook of Experimental Pharmacology, Vol. 74, Springer-Verlag, Berlin, 1985, pp. 101-130.
7. [7] Racine, R.J., Modification of seizure activity by electrical stimulation. II. Motor seizure, Electroenceph. clin. Neurophysiol., 32 (1972) 281-294.
8. 1-receptor antagonists on monoamine metabolism in the mouse brain, Naunyn-Schmiedeberg's Arch. Pharmacol., 343 (1991) 185-189.
9. [9] Verleden, G.M., Pype, J.L. and Demedts, M.M., Ketotifen modulates noncholinergic contraction in guinea pig airways in vitro by a prejunctional nonhistamine receptor, J. Allergy Clin. Immunol., 94 (1994) 207-214.
10. [10] Yanai, K., Ryu, J.H., Watanabe, T., Iwata, R., Ido, T., Asakura, M., Matsumura, R. and Itoh, M., Positron emission tomographic study of central histamine H1 receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine, Methodol. Findings Exp. Clin. Phamacol., 17 (1995) 64-69.
11. [11] Yokoyama, H. and Iinuma, K., Histamine and seizures: implications for the treatment of epilepsy, CNS Drugs, 5 (1996) 321-330.
12. [12] Yokoyama, H., Iinuma, K., Yagi, T. and Karahashi, M., Histaminergic neurons and epilepsy - clinical view, Methodol. Findings Exp. Clin. Pharmacol., 18 (1996) 181-186.
13. 1-antagonists on electrically-induced seizure in developing mice, Psychopharmacology, 112 (1993) 199-203.
14. 1 agonist decreases seizure susceptibility, Pharmacol. Biochem. Behav., 47 (1994) 503-507.
15. [15] Yokoyama, H., Onodera, K., Maeyama, K., Yanai, K., Iinuma, K., Tuomisto, L. and Watanabe, T., Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of α-fluoromethylhistidine and metoprine, Naunyn-Schmiedeberg's Arch. Pharmacol., 346 (1992) 40-45.
16. [16] Wada, H., Inagaki, N., Yamatodani, A. and Watanabe, T., Is the histaminergic neuron system a regulatory center for whole barin activity?, Trends Neurosci., 14 (1991) 415-419.
17. [17] Watababe, T., Taguchi, Y., Hayashi, H., Shiosaka, S., Tanaka, J., Kubota, H., Terano, Y., Tohyama, M., Kubota, H., Terano, Y. and Wada, H., Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker, Brain Res., 295 (1984) 13-25.